# Qidni Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/qidni-labs

- Industry: Medical Devices & Equipment
- Headquarters: Buffalo, US
- Website: www.qidni.life
- Total disclosed funding: $8.9M
- Latest round: Grant (Sep 23, 2026)
- Investors on record: 2

## About

Based in the US, Qidni Labs Inc. specializes in innovative dialysis technology, providing portable and accessible solutions for patients with kidney failure, enhancing patient care and treatment accessibility.Qidni Labs Inc., founded in 2014 and headquartered in Buffalo, US, focuses on developing advanced dialysis solutions. The firm has completed 2 deals, with the most recent funding round being a Series A which raised USD 0.730 mn. The company aims to improve dialysis access, particularly in underserved regions. The founder has a history of entrepreneurship, though specific details about prior ventures are not disclosed.Qidni Labs Inc. specializes in innovative dialysis technology designed to improve accessibility for patients with kidney failure. Their core offering is a miniaturized dialysis device that operates independently of traditional hemodialysis requirements, such as tap water and bulky purification systems. Instead, the Qidni device utilizes a minimal amount of saline solution, readily available at most drug stores, and can operate on rechargeable batteries, making it portable and usable in a variety of settings. This technology aims to address the significant gap in access to dialysis for up to 10 million patients globally, particularly in regions where conventional hemodialysis facilities are scarce. The target end users of this product include patients requiring dialysis treatment and healthcare providers who manage such patients, particularly in North America and potentially in other underserved global markets.Qidni Labs Inc. generates revenue through a business model that focuses on direct sales and partnerships with healthcare providers and institutions. The company’s flagship product, the Qidni device, is positioned to facilitate home and remote dialysis, catering to a market that values portability and ease of use. While specific pricing structures and transaction models have not been disclosed, it is expected that the company may leverage a combination of direct sales to consumers and partnerships with healthcare organizations to provide its devices. These transactions could involve bulk orders from hospitals and clinics, allowing them to offer convenient treatment options to their patients. Revenue streams may also extend to ongoing support and monitoring services, enhancing the overall patient experience and engagement with the technology.In August 2025, Qidni Labs Inc. raised USD 0.730 mn in Series A funding from new investor SOSV, which will be utilized to support the development of upcoming product features aimed at improving dialysis treatment. The company plans to expand into new markets, particularly targeting underserved regions in North America and beyond, though specific timelines have not been disclosed.

## Funding rounds

- Grant, Sep 23, 2026, $8.9M — Government of Canada
- Series A, Aug 12, 2025 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Series A
- Government of Canada — Grant